Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Seems desperation move offering cash back on this share option scheme, lol be nice if current holders get cash back!
Well this is surely going to pump up the price, they imported a mushroom, I nearly fell off my chair laughing. Been a long time investor here but just that made it worth the loss. Still not selling have a great day all.
Wow, these guys dont give up. Zomer and co. will succeed in the end!
They've got to be the only people into weed and 'shrooms who don't make any money! :)
More good news from MGC today:
*First import approval of psilocybin under the collaboration with Psyence
* First entry into the psilocybin market
* Enhances ambitions to be one of the first companies to provide Psilocybin treatments alongside its plant-based treatments
The key point here is that major pharma companies will be increasingly taking note of MGC as according to a recent Bloomberg report the global psychedelic therapeutics market was valued at US$ 3.61 billion in 2021 and it is expected to reach US$ 8.31 billion by 2028, with a CAGR of 13.2% during the forecast period of 2023-2028.
Patience is all that is required....
Good luck, Brighty
31/07/2023 7:00am
UK Regulatory (RNS & others)
Mgc Pharmaceuticals (LSE:MXC)
Intraday Stock Chart
Monday 31 July 2023
Click Here for more Mgc Pharmaceuticals Charts.
TIDMMXC
RNS Number : 6410H
MGC Pharmaceuticals Limited
31 July 2023
MGC Pharma receives permission for first import of Psilocybin
31 July 2023
ASX Code: MXC
LSE Code: MXC
Highlights :
-- First importation approval of Psilocybin Raw Mushrooms to MGC Slovenian Research
-- MGC will perform an analysis on the materials with a view to further developing analytical and stability methods on the Psilocybin mushrooms.
MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based pharmaceutical company specialising in the production and development of plant derived medicines, is pleased to announce it has been granted its first import permit for 200g of Psilocybin Raw Mushroom material to its Slovenian research facility from Psyence Group Inc's ('Psyence') Southern Africa production site as part of the material transfer agreement signed between the two companies.
Under the agreement, MGC Pharma will perform an analysis on the materials with a view to assist Psyence in the development of new psilocybin products to take to market, through its GMP-certified research facility in Slovenia that was recently approved for psilocybin compounding [1] .
Psyence is a life science biotechnology company listed on the Canadian Securities Exchange (CSE:PSYG) and quoted on the OTCQB (OTCQB:PSYGF), with a focus on natural psychedelics. Psyence works with natural psilocybin products for the healing of psychological trauma and its mental health consequences. Psyence operates out of one of the world's first federally licensed commercial psilocybin mushroom cultivation and production facilities in Southern Africa and works to develop advanced natural psilocybin products for clinical research and development.
Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. Psyence focuses on developing propriety natural psilocybin drug development and treatment protocols with a focus on palliative care. The company cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at its federally licensed facility.
Following MGC's successful audit of the Psyence production site to ensure that it meets the standards necessary to proceed with the export to MGC's European facilities, MGC has submitted and was granted the import approval of psilocybin. Psyence will complete the export on receipt of the export permit. Based on the analytical findings and results of the technical evaluation of the first delivery of 200g of Psilocybin Raw Mushrooms, MGC will develop analytical methods and stability testing to meet ICH guidelines.
Roby Zomer, CEO and Managing Director of MGC Pharmaceuticals, commented: "We are delighted to receive the first import approval of psilocybin under our collaboration with Psyence, which constitutes our first entry
Limited company call bank of new York base in London still very positive news they take more then 4.5 % think they are the biggest shareholders now
A subsidiary of the Bank of New York?
BNY (OCS) Nominees Limited takes 4.53% stake
https://www.londonstockexchange.com/news-article/MXC/holding-s-in-company/16051419
Then all that is left is behind the sofa cushions, piggie banks and then begging in the town center. Great rest of year coming up
4 insider buys ~ 16m shares. RNS / PDMR Notification is just out.
A lot lower in time, no turnaround here until the Mercer money is converted, any sp increase atm is to just offload the recent placing shares at a profit......just my opinion. .gla
There is a very good chance of that. Price is just beginning to rise.
Someone just 15,000,000
Someone purchased 15 million shares pre market. That is incredibly unusual, and a sure sign that this is heading sharply north.
A very good placing on Friday for those biting in now. Do your own research etc
I give you £50.00 if this goes to 0.20 tomorrow
BOD taking the placing
All the bad news out. I see this rerating now
Thanks for those replies. Yes, the dilution is significant and ongoing. Any opinions as to why Artemic isn't listed on their website? The website itself doesn't inspire my confidence tbh, but lack of their leading product is downright odd.
The last placing was at .44 and let's be fair, if you had bought in back then thinking the two million raised was significant....you would be well out off pocket now. Now we have a fanfare telling us about staff buying in at this new low, you would think this is the bottom.... we may have a mini spike, so they can make a few bob but with the Mercer facility still to be used and millions to be converted in time, this could easily go sub .10...gla
The answer to that is simple - DILUTION! The Company is still in development stages and therefore needs to raise capital until sales/profit stop the need to raise cash. The Company is indeed making progress and the foundations are being laid.
Good luck with your investment(s).
I would appreciate an answer to this also. And yes, I am a new (potential) investor.
Also, why the steady drop in SP? Seems they are making good progress from the RNS's. (I've been thru them all)
See you all over 0.20p very soon
See you all at sub 0.10. Very soon
Nice bit of buying in the last 5 minutes